FDA approves blood test to improve prostate Ca detection
Posted on July 12, 2012
The FDA recently granted pre-market approval to Prostate Health Index ( phi), a noninvasive blood test that manufacturer Beckman Coulter, Inc. claims is 2.5 times more specific in detecting prostate cancer than PSA in patients with PSA values in the 4.0 to 10.0 ng/mL range. “Prostate Health Index is a…
Dr. Whang comments : here is another test to help improve accuracy of PSA blood test. We already have Total and Free PSA but this could be an important addition.
Posted in Uncategorized